Labetalol hydrochloride 5 mg / mL Injection 20 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 25021-0317-20 |
|---|---|
| Product NDC | 25021-0317 |
| Generic Drug Name | labetalol hydrochloride |
| Brand Name | labetalol hydrochloride |
| Manufacturer | Sagent Pharmaceuticals |
| Strength | 5 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (25021-317-20) / 20 mL in 1 VIAL |
| Active Ingredients | Labetalol Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
labetalol hydrochloride 5 mg / mL Injection is tracked under NDC 25021-0317-20 and rolls up into product family 25021-0317. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial.
- Manufacturer: Sagent Pharmaceuticals.
- Dosage form: Injection.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 11 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative Hublabetalol hydrochloride 5 mg / mL Injection 20 mL Vial12 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Documented shortage history shows this labetalol hydrochloride NDC was listed in 2022, following ingredient-level shortage bulletins in 2015 and 2017, which suggests elevated future supply risk.
Drug Shortage Index family
View Labetalol hydrochloride in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Labetalol hydrochloride.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Labetalol hydrochloride 5 mg / mL Injection 20 mL, NDC 25021-0317-20, is a Sagent Pharmaceuticals 5 mg / mL injection presentation packaged as 1 Vial. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 25021-0317-20
- Digits-only NDC 11: 25021031720
- Possible 10-digit display format: 25021-317-20 (2502131720)
Helpful product links
- Search by brand name: labetalol hydrochloride
- NDC 11: 25021-0317-20
- Product family NDC: 25021-0317
- Compare related presentations: Labetalol hydrochloride 5 mg / mL Injection 40 mL
- VA classification code: CV100
- VA classification code description: BETA BLOCKERS/RELATED
- VUID: 4006599